☰

Martin Wahlestedt - Publications

Affiliations: 
2009-2014 Lund Stem Cell Center Lund University, Lund, Skåne län, Sweden 
Website:
https://portal.research.lu.se/portal/en/persons/martin-wahlestedt(528252d5-2b40-4d93-b359-36a0042706fc).html
Tree Info Similar researchers PubMed Report error

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Hidalgo I, Wahlestedt M, Yuan O, Zhang Q, Bryder D, Pronk CJ. Bmi1 induction protects hematopoietic stem cells against pronounced long-term hematopoietic stress. Experimental Hematology. PMID 35192914 DOI: 10.1016/j.exphem.2022.02.004  0.793
2017 Komorowska K, Doyle A, Wahlestedt M, Subramaniam A, Debnath S, Chen J, Soneji S, Van Handel B, Mikkola HKA, Miharada K, Bryder D, Larsson J, Magnusson M. Hepatic Leukemia Factor Maintains Quiescence of Hematopoietic Stem Cells and Protects the Stem Cell Pool during Regeneration. Cell Reports. 21: 3514-3523. PMID 29262330 DOI: 10.1016/J.Celrep.2017.11.084  0.763
2017 Wahlestedt M, Ladopoulos V, Hidalgo I, Sanchez Castillo M, Hannah R, Säwén P, Wan H, Dudenhöffer-Pfeifer M, Magnusson M, Norddahl GL, Göttgens B, Bryder D. Critical Modulation of Hematopoietic Lineage Fate by Hepatic Leukemia Factor. Cell Reports. 21: 2251-2263. PMID 29166614 DOI: 10.1016/J.Celrep.2017.10.112  0.8
2017 Wahlestedt M, Bryder D. The slippery slope of hematopoietic stem cell aging. Experimental Hematology. PMID 28943295 DOI: 10.1016/J.Exphem.2017.09.008  0.756
2017 Wahlestedt M, Erlandsson E, Kristiansen T, Lu R, Brakebusch C, Weissman IL, Yuan J, Martin-Gonzalez J, Bryder D. Clonal reversal of ageing-associated stem cell lineage bias via a pluripotent intermediate. Nature Communications. 8: 14533. PMID 28224997 DOI: 10.1038/Ncomms14533  0.78
2017 Ugale A, Säwén P, Dudenhöffer-Pfeifer M, Wahlestedt M, Norddahl GL, Bryder D. MLL-ENL-mediated leukemia initiation at the interface of lymphoid commitment. Oncogene. 36: 3207-3212. PMID 28068328 DOI: 10.1038/Onc.2016.470  0.771
2017 Jaako P, Ugale A, Wahlestedt M, Velasco-Hernandez T, Cammenga J, Lindström MS, Bryder D. Induction of the 5S RNP-Mdm2-p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia. Leukemia. 31: 213-221. PMID 27256803 DOI: 10.1038/Leu.2016.159  0.745
2015 Wahlestedt M, Pronk CJ, Bryder D. Concise review: hematopoietic stem cell aging and the prospects for rejuvenation. Stem Cells Translational Medicine. 4: 186-94. PMID 25548388 DOI: 10.5966/Sctm.2014-0132  0.833
2014 Ugale A, Norddahl GL, Wahlestedt M, Säwén P, Jaako P, Pronk CJ, Soneji S, Cammenga J, Bryder D. Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation. Cell Reports. 9: 1246-55. PMID 25456127 DOI: 10.1016/J.Celrep.2014.10.036  0.759
2014 Wahlestedt M, Bryder D. Induced hematopoietic stem cells: unlocking restrictions in lineage potential and self-renewal. Cell Stem Cell. 14: 555-6. PMID 24792111 DOI: 10.1016/J.Stem.2014.04.008  0.727
2014 Wahlestedt M, Ameur A, Moraghebi R, Norddahl GL, Sten G, Woods NB, Bryder D. Somatic cells with a heavy mitochondrial DNA mutational load render induced pluripotent stem cells with distinct differentiation defects. Stem Cells (Dayton, Ohio). 32: 1173-82. PMID 24446123 DOI: 10.1002/Stem.1630  0.792
2014 Wahlestedt M, Säwén P, Ladopoulos V, Norddahl G, Gottgens B, Bryder D. Critical modulation of hematopoietic lineage fate by the PAR/bZIP transcription factor hepatic leukemia factor Experimental Hematology. 42: S64. DOI: 10.1016/J.Exphem.2014.07.246  0.73
2013 Wahlestedt M, Norddahl GL, Sten G, Ugale A, Frisk MA, Mattsson R, Deierborg T, Sigvardsson M, Bryder D. An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state. Blood. 121: 4257-64. PMID 23476050 DOI: 10.1182/Blood-2012-11-469080  0.794
2013 Hansen N, Ã…gerstam H, Wahlestedt M, Landberg N, Askmyr M, Ehinger M, Rissler M, Lilljebjörn H, Johnels P, Ishiko J, Melo JV, Alexander WS, Bryder D, JärÃ¥s M, Fioretos T. SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function. Leukemia. 27: 130-5. PMID 22824785 DOI: 10.1038/Leu.2012.169  0.732
2012 Norddahl GL, Wahlestedt M, Gisler S, Sigvardsson M, Bryder D. Reduced repression of cytokine signaling ameliorates age-induced decline in hematopoietic stem cell function. Aging Cell. 11: 1128-31. PMID 22809070 DOI: 10.1111/J.1474-9726.2012.00863.X  0.807
2011 Norddahl GL, Pronk CJ, Wahlestedt M, Sten G, Nygren JM, Ugale A, Sigvardsson M, Bryder D. Accumulating mitochondrial DNA mutations drive premature hematopoietic aging phenotypes distinct from physiological stem cell aging. Cell Stem Cell. 8: 499-510. PMID 21549326 DOI: 10.1016/J.Stem.2011.03.009  0.792
2011 Hansen N, Agerstam H, Wahlestedt M, Ehinger M, Johnels P, Ishiko J, Melo JV, Alexander WS, Bryder D, Järås M, Fioretos T. Socs2 Is Dispensable for BCR/ABL1-Induced Chronic Myeloid Leukemia-Like Disease in Mice and for Normal Hematopoietic Stem Cell Function, Blood. 118: 3743-3743. DOI: 10.1182/Blood.V118.21.3743.3743  0.709
2011 Norddahl GL, Wahlestedt M, Gisler S, Sigvardsson M, Bryder D. Enhanced Cytokine Responsiveness Counteracts Age-Induced Decline in Hematopoietic Stem Cell Function Blood. 118: 2342-2342. DOI: 10.1182/Blood.V118.21.2342.2342  0.799
Show low-probability matches.